8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2007 / Before-and-after intervention study
Researchers measured the DNA fragmentation index and the degree of sperm decondensation using the sperm chromatin structure assay before and after 90 days of treatment with antioxidant vitamins combined with zinc and selenium. Treatment resulted in a 19.1% decrease in sperm DNA fragmentation (P < 0.0004). However, it also led to an unexpected 22.8% increase in sperm decondensation (P < 0.0009).
Ménézo YJ, Hazout A, Panteix G, et al. Reprod Biomed Online, 2007. PMID 17425820
2007 / Randomized crossover trial
Sixty healthy postmenopausal women were randomized in a crossover design to an 8-week Therapeutic Lifestyle Changes (TLC) diet alone or a TLC diet where one-half cup of soy nuts (providing 25 g soy protein and 101 mg aglycone isoflavones) replaced 25 g of nonsoy protein. Compared to TLC alone, the TLC diet plus soy nuts was associated with a 45% decrease in hot flashes in women with >4.5 hot flashes/day at baseline (7.5 +/- 3.6 vs. 4.1 +/- 2.6/day, p < 0.001) and a 41% decrease in those with <=4.5/day (2.2 +/- 1.2 vs. 1.3 +/- 1.1, p < 0.001). Soy nut intake also significantly improved quality-of-life scores, with decreases in vasomotor (19%, p = 0.004), psychosocial (12.9%, p = 0.01), and physical scores (9.7%, p = 0.045), and a 17.7% reduction in sexual symptoms (p = 0.129). Exercise amount had no effect on hot flash reduction.
Welty FK, Lee KS, Lew NS, et al. J Womens Health (Larchmt), 2007. PMID 17439381
2007 / Double-blind, placebo-controlled randomized trial
A double-blind, placebo-controlled clinical trial evaluated the effects of lutein and zeaxanthin administered orally, topically, or via combined oral and topical routes on five skin physiology parameters in human subjects. Combined oral and topical administration offered the highest degree of antioxidant protection, though individual oral and topical administration also showed significant activity in the skin. Furthermore, oral lutein administration appeared to provide better protection than topical application when evaluating changes in lipid peroxidation and photoprotective activity after UV irradiation.
Palombo P, Fabrizi G, Ruocco V, et al. Skin Pharmacol Physiol, 2007. PMID 17446716
2007 / Randomized controlled trial
Thirty-three patients with perennial allergic rhinitis were randomized to take 360 mg per day of oral tomato extract or placebo for 8 weeks. Sneezing scores (p < 0.05) and combined total symptom scores (p < 0.01) decreased significantly after 8 weeks of tomato extract. Quality of life also improved significantly in the extract group (p < 0.05), whereas no improvement occurred in the placebo group.
Yoshimura M, Enomoto T, Dake Y, et al. Allergol Int, 2007. PMID 17519582
2007 / Randomized crossover trial
A randomized, double-blind crossover trial examined the effects of pomegranate juice versus placebo over two 4-week periods in 53 men with mild to moderate erectile dysfunction. Although 25 of 42 participants who improved on the questionnaire did so after consuming pomegranate juice (P=0.058), the overall difference between the beverages failed to achieve statistical significance. No significant efficacy was demonstrated.
Forest CP, Padma-Nathan H, Liker HR Int J Impot Res, 2007. PMID 17568759
2007 / Placebo-controlled trial and animal experiment
Researchers evaluated the effects of capsaicin and isoflavone on hair growth and IGF-I levels in mice and in 48 volunteers with alopecia over 5 months. In the human trial, 31 volunteers received oral capsaicin (6 mg/day) and isoflavone (75 mg/day), while 17 received placebo. Plasma IGF-I levels significantly increased from baseline in the intervention group (p < 0.01) but not in the placebo group. Promotion of hair growth was significantly higher in the intervention group (20/31, 64.5%) compared to the placebo group (2/17, 11.8%) at 5 months (p < 0.01).
Harada N, Okajima K, Arai M, et al. Growth Horm IGF Res, 2007. PMID 17569567
2007 / Randomized controlled trial
A randomized controlled trial examined 59 women with metabolic syndrome and female sexual dysfunction assigned to a Mediterranean-style diet (n = 31) or a control diet (n = 28). After 2 years, total Female Sexual Function Index scores improved from 19.7 +/- 3.1 to 26.1 +/- 4.1 in the intervention group (P = 0.01) but remained stable in controls. C-reactive protein levels were reduced in the intervention group (P < 0.02), though no individual sexual domain showed statistically significant improvement.
NANO counterpoint →
Esposito K, Ciotola M, Giugliano F, et al. Int J Impot Res, 2007. PMID 17673936
2007 / Phase 2 pilot clinical trial
A phase 2 pilot study assessed the tolerability and effect of 40 g of daily crushed flaxseed for 6 weeks in 30 women experiencing at least 14 hot flashes per week. After treatment, the mean decrease in hot flash scores was 57% (median decrease 62%), and the mean reduction in daily hot flash frequency was 50% (median reduction 50%), decreasing from 7.3 to 3.6 hot flashes. Mild or moderate abdominal distention occurred in 14 of 28 participants (50%), mild diarrhea in 8 (29%), flatulence in one, and six participants (21%) withdrew because of toxicities.
Pruthi S, Thompson SL, Novotny PJ, et al. J Soc Integr Oncol, 2007. PMID 17761129
2007 / Intervention study (pre-post with working day control)
Twelve healthy male subjects participated in a 3-day/2-night trip across three forest fields, involving scheduled 2-hour walks, to investigate the effect of forest bathing on immune function. Measurements were compared to a baseline normal working day. Almost all subjects (11/12) showed higher NK activity after the trip (about 50 percent increased). The trip also significantly increased the numbers of NK cells and cells expressing perforin, granulysin, and granzymes A/B.
Li Q, Morimoto K, Nakadai A, et al. Int J Immunopathol Pharmacol, 2007. PMID 17903349
2007 / Randomized double-blind placebo-controlled trial
Healthy adults aged 18 to 70 took green tea capsules or placebo twice daily for 3 months in a randomized trial. Participants taking the supplement had 32.1% fewer individuals with symptoms (P = 0.035) and 35.6% fewer symptom days (P < 0.002). In addition, their cultured gamma,delta T cells showed 28% greater proliferation (P = 0.017) and 26% higher interferon-gamma secretion (P = 0.046).
Rowe CA, Nantz MP, Bukowski JF, et al. J Am Coll Nutr, 2007. PMID 17914132
2007 / Intervention trial with animal and human components
Researchers evaluated the protective effects of topical sulforaphane-rich extracts of 3-day-old broccoli sprouts against UV radiation in mice and humans. In six human subjects (three males and three females, 28-53 years of age), the extract up-regulated phase 2 enzymes and achieved a mean reduction in erythema across six UVR doses (300-800 mJ/cm² in 100 mJ/cm² increments) of 37.7% (range 8.37-78.1%; P = 0.025).
Talalay P, Fahey JW, Healy ZR, et al. Proc Natl Acad Sci U S A, 2007. PMID 17956979
2007 / Single-blind, controlled, randomized crossover trial
Twenty-eight children with atopic dermatitis and cow's milk allergy were randomized to receive ass's milk or goat's milk for 6 months, followed by a 3-month switch to the other milk; 26 completed the study. Ass's milk led to a significant improvement in the SCORAD index and VAS of symptoms (p < 0.03 vs. baseline and inter-group), while goat's milk showed no measurable clinical effect. Following the study, 23 of 26 children had a positive food challenge to goat's milk compared to only 1 of 26 with ass's milk. Protein profile analysis indicated ass's milk was closer to human milk than goat's milk.
Vita D, Passalacqua G, Di Pasquale G, et al. Pediatr Allergy Immunol, 2007. PMID 18001430
2007 / Randomised, double-blind, parallel, split-mouth trial
In a randomised, double-blind, split-mouth trial, 20 systemically healthy patients with gingivitis were assigned to 8 mg lycopene/day (n = 10) or placebo (n = 10) for 2 weeks, with two quadrants receiving oral prophylaxis (OP) and two quadrants untreated (non-OP). OP-lycopene led to a statistically significant decrease in GI compared with OP-placebo (p < 0.05) and non-OP-placebo (p < 0.01), while non-OP-lycopene reduced GI compared with non-OP-placebo (p < 0.01). OP-lycopene also reduced SBI compared with non-OP-lycopene (p < 0.05) and non-OP-placebo (p < 0.001). A strong negative correlation was found between salivary uric acid levels and percentage reduction in GI at 1 and 2 weeks in the OP-lycopene group (r = -0.852 and -0.802) and non-OP-lycopene group (r = -0.640 and -0.580).
Chandra RV, Prabhuji ML, Roopa DA, et al. Oral Health Prev Dent, 2007. PMID 18173095
2006 / Pharmacokinetic intervention study
Eighteen subjects with osteoarthritis were administered 1,500 mg of commercial glucosamine sulphate after an overnight fast, with serum collected over 3 hours (and up to 8 hours in two subjects). Baseline serum glucosamine was below the 0.5 mumol/l detection limit in all subjects. After ingestion, glucosamine was detected in 17 of 18 subjects, rising at 30-45 minutes to a maximum at 90-180 minutes with a range of 1.9-11.5 micromol/l (0.34-2 microg/ml). The authors note this peak concentration is far lower than levels claimed to have in vitro effects.
Biggee BA, Blinn CM, McAlindon TE, et al. Ann Rheum Dis, 2006. PMID 16079170
2006 / Randomized controlled trial
Sixty young healthy adults were randomized to a 45-minute dynamic exercise, mental stress, or control task condition immediately prior to receiving an influenza vaccine. For the A/Panama strain, women in both the exercise and mental stress groups exhibited higher antibody titres at 4 and 20 weeks compared to the control condition, whereas men showed similar responses across all conditions. Interleukin-6 measured at 60 minutes of recovery was a significant predictor of the subsequent A/Panama antibody response in women.
Edwards KM, Burns VE, Reynolds T, et al. Brain Behav Immun, 2006. PMID 16102936
2006 / Crossover experimental trial
Researchers measured cardiovascular and respiratory variables in 12 musicians and 12 age-matched controls while they listened to six music styles in random order with a randomly inserted two-minute pause. Faster tempi and simpler rhythmic structures increased ventilation, blood pressure, and heart rate, while decreasing mid-cerebral artery flow velocity and baroreflex compared with baseline. The pause reduced heart rate, blood pressure, and minute ventilation, even below baseline levels. Musicians demonstrated greater respiratory sensitivity to music tempo than non-musicians.
Bernardi L, Porta C, Sleight P Heart, 2006. PMID 16199412
2006 / Randomized controlled trial
In a double-blind trial, 30 patients with stable chronic obstructive pulmonary disease consumed 400 ml of pomegranate juice or placebo daily for five weeks. No differences were observed between groups for respiratory function, clinical symptoms, serobiochemical or hematological markers, or urinary isoprostane (p > 0.05). Pomegranate polyphenols were not detected intact in plasma or urine, yielding only non-antioxidant microbial metabolites.
Cerdá B, Soto C, Albaladejo MD, et al. Eur J Clin Nutr, 2006. PMID 16278692
2006 / Randomized, cross-over trial
Thirty-six perimenopausal and postmenopausal women participated in a randomized cross-over trial with two 12-week diet periods (a soy-free control diet and an isocaloric soy-rich diet with 25 g soy protein providing over 50 mg/day of isoflavones) separated and preceded by 4-week washout periods. Symptoms of urge incontinence and vaginal dryness significantly increased after 12 weeks of the soy-free diet, but all other urogenital symptoms remained unchanged in both periods. Furthermore, the vaginal health index, vaginal pH, karyopyknotic index, and maturation value did not significantly change in either period.
Manonai J, Songchitsomboon S, Chanda K, et al. Maturitas, 2006. PMID 16297576
2006 / Randomized controlled trial
A 12-week trial evaluated hop extract standardized to 100 or 250 micrograms of 8-prenylnaringenin against placebo in 67 menopausal women. The 100-microgram dose reduced modified Kupperman index scores significantly more than placebo at six weeks (P = 0.023), but this difference was not maintained at 12 weeks (P = 0.086). Both doses significantly decreased hot flush scores at six weeks (P < 0.01), though the higher dose was less active overall.
Heyerick A, Vervarcke S, Depypere H, et al. Maturitas, 2006. PMID 16321485
2006 / Open 1:1:1 dose-escalation phase I trial
An open phase I dose-escalation study evaluated oral soluble branched yeast beta-1,3-D-glucan (SBG) given once daily for 4 consecutive days at 100 mg/day, 200 mg/day, or 400 mg/day in groups of 6 healthy non-smoking volunteers. No drug-related adverse events were observed, and repeated serum measurements revealed no systemic absorption. Saliva immunoglobulin A concentrations increased significantly at the highest dose of 400 mg/day.
Lehne G, Haneberg B, Gaustad P, et al. Clin Exp Immunol, 2006. PMID 16367935
2006 / Controlled trial with matched groups
Human volunteers performed cycling or handgrip training 3-4 times a week for 4-6 weeks, with exercised limbs assigned to post-exercise cold-water immersion or room temperature. Significant training effects were three times more frequent in the control group than in the cold group. Additionally, increases in artery diameters occurred in the control group but not in the cold group.
Yamane M, Teruya H, Nakano M, et al. Eur J Appl Physiol, 2006. PMID 16372177
2006 / Randomized controlled trial
A randomized controlled trial evaluated the effects of 4 months of didgeridoo lessons and daily home practice compared to a waiting list control group in 25 patients with moderate obstructive sleep apnoea. Participants practiced an average of 5.9 days per week for 25.3 minutes. Compared with controls, the didgeridoo group showed significant improvements in daytime sleepiness (difference -3.0, 95% CI -5.7 to -0.3, P = 0.03), apnoea-hypopnoea index (difference -6.2, -12.3 to -0.1, P = 0.05), and partner-rated sleep disturbance (difference -2.8, -4.7 to -0.9, P < 0.01). No significant effects were observed on sleep quality (difference -0.7, -2.1 to 0.6, P = 0.27) or health-related quality of life.
Puhan MA, Suarez A, Lo Cascio C, et al. BMJ, 2006. PMID 16377643
2006 / Controlled clinical trial
In a controlled trial, 65 men with metabolic syndrome and erectile dysfunction were assigned to a Mediterranean-style diet (n = 35) or a control diet (n = 30) for two years. After two years, endothelial function scores and C-reactive protein levels improved in the intervention group but remained stable in controls. In addition, 13 men in the intervention group versus two in the control group reported an International Index of Erectile Function (IIEF) score of 22 or higher (P = 0.015).
NANO counterpoint →
Esposito K, Ciotola M, Giugliano F, et al. Int J Impot Res, 2006. PMID 16395320
2006 / Double-blind, randomized, placebo-controlled trial
In a double-blind, placebo-controlled trial, 41 statin-treated patients consumed a control margarine for 4 weeks and were then randomized for 16 weeks to receive daily control margarine (n=11), 2.5 g plant sterol ester-enriched margarine (n=15), or 2.5 g plant stanol ester-enriched margarine (n=15). Despite significant (P = 0.004) increases of 42% and 59% in cholesterol-standardized serum sitosterol and campesterol concentrations in the plant sterol group versus control, red blood cell campesterol levels did not change (P = 0.196). Osmotic fragility showed no significant change (P = 0.757) in either the plant sterol or stanol groups compared with controls.
de Jong A, Plat J, Mensink RP Eur J Clin Nutr, 2006. PMID 16482072